Free Daily Podcast Summary
Eyewire News: The Podcast: Daily Summaries Delivered
by Eyewire News
Eyewire News: The Podcast keeps listeners updated with the latest information in the ophthalmic field, featuring breaking news from press releases, medical journals, vision publications, and other news sources.
Latest Episodes
The most recent episodes — sign up to get AI-powered summaries of each one.
- 5 days ago10 min
Breaking News From the ESCRS Congress in London (Part 1 of 2)
EyewireTV reports on new products and breaking news live from the ESCRS Congress in London. Learn more about your ad choices. Visit megaphone.fm/adchoices
- 1 weeks ago4 min
FDA Accepts Nanoscopes's Optogenetic Gene Therapy BLA
The FDA accepts a biologics license application (BLA) for a first-of-its-kind optogenetic gene therapy for RP; a software upgrade from Heru combines several pretesting assessments into a single guided workflow; and a new FDA-approved overnight orthokeratology lens is launched in the US. Learn more about your ad choices. Visit megaphone.fm/adchoices
- 2 weeks ago6 min
FDA Sets PDUFA Date for Investigational Glaucoma Eye Drop
The FDA accepts Nicox’s NDA for an investigational glaucoma drop; Bausch + Lomb provides updates on two key investigational therapies for dry eye and ocular surface pain; and Ocugen doses the first patient in a global phase 3 trial of an investigational gene therapy for geographic atrophy (GA). Learn more about your ad choices. Visit megaphone.fm/adchoices
- 3 weeks ago5 min
EyePoint Misses Primary Endpoint in Phase 3 Trial But Sees Promise After Analysis
Eyepoint Pharmaceuticals releases key phase 3 data for its wet AMD drug Duravyu; Zeiss receives FDA clearance for a cloud- and browser-based data management solution; and the FDA expands Sight Sciences’ indications for the TearCare System for the treatment of MGD. Learn more about your ad choices. Visit megaphone.fm/adchoices
- Aug 12, 20265 min
Three Major Acquisitions Announced in Ophthalmology
Tarsus Pharmaceuticals enters into a definitive agreement to acquire Alkeus Pharmaceuticals; Harrow acquires dry eye disease nasal spray Tyrvaya from Viatris; and Italy-based Alfasigma enters into a share purchase agreement with Sever Life Sciences to acquire 100% of Nordic Pharma and its subsidiaries. Learn more about your ad choices. Visit megaphone.fm/adchoices
- Aug 5, 20264 min
Biocon Launches Eylea Biosimilar Yesafili
An interchangeable biosimilar to Eylea is launched in the US; patient enrollment is completed in two global phase 3 clinical trials evaluating Duravyu for diabetic macular edema; and Topcon receives CE mark for a fully automated ultra-widefield retinal slit scanner. Learn more about your ad choices. Visit megaphone.fm/adchoices
- Jul 29, 202611 min
FDA Approves Outlook's Lytenava for Wet AMD
The CEO of Outlook Therapeutics discusses the FDA approval of wet AMD drug Lytenava; Roche receives a major boost in its efforts to commercialize wet AMD treatment Susvimo in Europe; and Glaukos reaches a milestone in its pivotal clinical study of the Preserflo MicroShunt. Learn more about your ad choices. Visit megaphone.fm/adchoices
- Jul 22, 20265 min
PRIMA Retinal Implant Launched in EU
A retinal implant system allowing patients with GA to regain some functional central vision vison is approved in Europe; Bausch + Lomb launches a new preloaded IOL delivery system in the US; and we review recent advancements and milestones in the development of novel ophthalmic treatments. Learn more about your ad choices. Visit megaphone.fm/adchoices
Customized Recaps
AI-powered recaps with compact key takeaways, quotes, and insights.
Straight to Your Inbox
Get key takeaways from Eyewire News: The Podcast in a 5-minute read.
Save Hours Every Week
Stay current on your favorite podcasts without falling behind.
Frequently Asked Questions
What is Podzilla's Eyewire News: The Podcast daily summary?
It's a free AI-powered email that summarizes new episodes of Eyewire News: The Podcast as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
How does the Eyewire News: The Podcast podcast summary work?
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
Is this an official Eyewire News: The Podcast product?
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Eyewire News.
Can I get summaries of other podcasts too?
Absolutely! The free plan covers up to 3 podcasts. Upgrade to Pro for 15, or Premium for 50. Browse our full catalog at /podcasts.
How often does Eyewire News: The Podcast release new episodes?
Eyewire News: The Podcast publishes weekly. Our AI generates a summary within hours of each new episode.
What topics does Eyewire News: The Podcast cover?
Eyewire News: The Podcast covers topics including News, Business. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Start getting Eyewire News: The Podcast summaries tomorrow morning.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.